Metraipolis › archive › dc_062d3dbb1c4e
The role of EZH2 dysregulation in the pathogenesis of B-cell lymphomas and its implications as a target therapy — Europe PMC PMID:42211521
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42211521
- DOI
- 10.3389/fonc.2026.1843273
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T07:35:17.413Z
- SHA-256 of the archived text
ea701e515c89df265db9eaa94c3e0f851528a1f8dbe291284a3bf33a7ac7b300- Stable URL of this page
https://metraipolis.com/documento/dc_062d3dbb1c4e
How to cite
The role of EZH2 dysregulation in the pathogenesis of B-cell lymphomas and its implications as a target therapy — Europe PMC PMID:42211521 — Europe PMC (en), https://europepmc.org/article/MED/42211521 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_062d3dbb1c4e (Metraipolis archive dc_062d3dbb1c4e, sha256 ea701e515c89df265db9eaa94c3e0f851528a1f8dbe291284a3bf33a7ac7b300)
BibTeX
@misc{dc062d3dbb1c4e,
title = {The role of EZH2 dysregulation in the pathogenesis of B-cell lymphomas and its implications as a target therapy — Europe PMC PMID:42211521},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42211521},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_062d3dbb1c4e; sha256 ea701e515c89df265db9eaa94c3e0f851528a1f8dbe291284a3bf33a7ac7b300},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42211521. Agents can read the archived copy with the MCP tool read_document.